InvestSMART
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Managed Funds
  5. Colonial Managed Investment Funds - Global Health & Biotech NEF - Managed fund profile

Colonial Managed Investment Funds - Global Health & Biotech NEF - Managed Fund (Closed)

Fund Objective
To provide long-term capital growth.
Fund Strategy
Invests in listed companies around the world, whose primary business is in the fields of pharmaceuticals, biotechnology, medical devices, or medical services. Investments: Australian and international shares 80-100%, cash 0-20%. At least 80% of the value of the Fund must be located outside Australia. Shares are held in at least 25 companies.

Fund Performance Comparison

Relative Fund Performance vs {{ fund.benchmark.peers.peerCount }} peers using {{ fund.benchmark.name }} as their benchmark.

{{ fund.name }}
Peers
Benchmark ({{ fund.benchmark.name }})
{{ fund.model.name }}
The performance of the peers is calculated as the total of the performance for each time period for all the funds in the peer group, divided by the number of funds in the peer group.
grow your money
Grow your money, not your fees
It's fees rather than returns that make the biggest difference to your investment's compounding returns.
Free Fees Report
investing
Investing made simple
Our professionally-tailored investment portfolios consistently beat most of our peers.
Free investor guide
Grow your money, not your fees
It's fees rather than returns that make the biggest difference to your investment's compounding returns. Free Fees Report
Investing made simple
Our professionally-tailored investment portfolios consistently beat most of our peers. Free investor guide

Fees Comparison

{{ fund.mer | number:2 }}
% p.a.
{{ fund.name }}
{{ modelPortfolio.mer * 100 | number:2 }}
% p.a.
{{ modelPortfolio.name }}
{{ fund.benchmark.peers.mer * 100 | number:2 }}
% p.a.
Average of peers ({{ fund.benchmark.peers.peerCount }})
NOTE: Fee data has been provided by Morningstar, it may not include all costs being charged on your investment such as platform and adviser fees. You should check your fund manager or adviser statements to find out the exact fees you are being charged. Peers are funds that use the same benchmark in the Morningstar database.
Upsell Banner

Fund performance

  1M 3M 6M 1Y p.a. 2Y p.a. 3Y p.a. 5Y p.a. 10Y p.a.
Total return -3.1% 0.1% -6.14% -1% 1.7% -12.12% -% -%
Growth return -3.1% 0.1% -6.14% -1% 1.7% -12.12% -% -%
Income return 0% 0% 0% 0% 0% 0% -% -%
Market index (MSCI World Ex Australia NR AUD)
Total return 3.02% 14.06% 20.11% 28.72% 15.87% 14.43% -% 13.43%
As at 28 Feb 2005. Returns for periods greater than 1 year are annualised. All figures are percentages.

Asset Allocation

Colonial Managed Investment Funds - Global Health & Biotech NEF
International Equities
95.22%
Cash
4.78%
Australian Equities
0%
Property
0%
Fixed Interest
0%
Alternatives
0%
Average Allocation of Peers
International Equities
92.31%
Cash
3.56%
Australian Equities
2.34%
Property
1.76%
Fixed Interest
-0.04%
Alternatives
0.06%

General Information

Fund Details
Type Description
Colonial Managed Investment Funds - Global Health & Biotech NEF
Closed
Colonial First State Investments Limited
FSF0210AU
Equity World Other
Not Rated
Investment Fund
5 Dec 2001
$0.13 million (as at 28 Feb 2005)
$0.5965 (as at 4 Mar 2005)
$0.5935 (as at 4 Mar 2005)
Finalised
Offer information
Type Description
Indirect Cost Ratio (ICR) 0% (as at 31 Aug 2008)
Minimum initial investment $1,000.00

FAQs about the Colonial Managed Investment Funds - Global Health & Biotech NEF

The objective of the Colonial Managed Investment Funds - Global Health & Biotech NEF managed fund is To provide long-term capital growth.

The strategy of the Colonial Managed Investment Funds - Global Health & Biotech NEF managed fund is Invests in listed companies around the world, whose primary business is in the fields of pharmaceuticals, biotechnology, medical devices, or medical services. Investments: Australian and international shares 80-100%, cash 0-20%. At least 80% of the value of the Fund must be located outside Australia. Shares are held in at least 25 companies.

The APIR code of the Colonial Managed Investment Funds - Global Health & Biotech NEF managed fund is FSF0210AU.

Colonial Managed Investment Funds - Global Health & Biotech NEF’s total return last month was -3.1%. This was made up of a growth return of -3.1% and an income return of 0%. These returns were calculated as at 28 Feb 2005.

Colonial Managed Investment Funds - Global Health & Biotech NEF’s total return for the last three months was 0.1%. This was made up of a growth return of 0.1% and an income return of 0%%. These returns were calculated as at 28 Feb 2005.

Colonial Managed Investment Funds - Global Health & Biotech NEF’s one-year total return is -1%. This was made up of a growth return of -1% and an income return of 0%. These returns were calculated as at 28 Feb 2005.

Colonial Managed Investment Funds - Global Health & Biotech NEF’s one-year total return is -12.12%. This was made up of a growth return of -12.12% and an income return of 0%. These returns were calculated as at 28 Feb 2005.

The asset allocation of the Colonial Managed Investment Funds - Global Health & Biotech NEF managed fund is :

International Equities
95.22%
Cash
4.78%
Australian Equities
0%
Property
0%
Fixed Interest
0%
Alternatives
0%

The Responsible Entity for the Colonial Managed Investment Funds - Global Health & Biotech NEF managed fund is Colonial First State Investments Limited.

The Colonial Managed Investment Funds - Global Health & Biotech NEF managed fund belongs to the Equity World Other sector/asset class.

As at 28 Feb 2005, the size of the Colonial Managed Investment Funds - Global Health & Biotech NEF managed fund was $0.13 million.

The Colonial Managed Investment Funds - Global Health & Biotech NEF managed fund has an inception date of 5 Dec 2001.

The current entry price of the Colonial Managed Investment Funds - Global Health & Biotech NEF managed fund is $0.5965 per unit and the current exit price is $0.5935 per unit (as at 4 Mar 2005).

The current exit price of the Colonial Managed Investment Funds - Global Health & Biotech NEF managed fund is $0.5935 per unit and the current entry price is $0.5965 per unit (as at 4 Mar 2005).

The minimum initial investment amount for the Colonial Managed Investment Funds - Global Health & Biotech NEF managed fund is $1,000.

Fund data sourced from Morningstar. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only. Whilst every care has been taken in producing these numbers, neither Morningstar nor InvestSMART can make any guarantees around the complete accuracy of these figures. Should you decide to change investments, please read all relevant disclosure documents including the Product Disclosure Statements and if required, you may consider speaking to a financial professional for further guidance. A tax event may be realised as a result of switching investments. Past performance is not a reliable indicator of future performance.